🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety and immune response to two experimental vaccines when ...
Status
Completed
Location
JHU AVEG
Start Date
TBD
Trial ID
NCT00001096
Treatments Being Tested
This clinical study aims to determine which of two medications-dexamethason...
Status
Recruiting
Location
Poznan University of Medical Sciences
Start Date
2025-09-01
Trial ID
NCT07180940
Treatments Being Tested
To determine the safety and immunogenicity of Env 2-3 in combination with M...
Status
Completed
Location
Univ. of Rochester AVEG
Start Date
TBD
Trial ID
NCT00000958
Treatments Being Tested
The purpose of this randomized, triple-blinded, prospective, feasibility st...
Status
Completed
Location
Wake Forest Health Sciences
Start Date
2023-03-24
Trial ID
NCT05676814
Treatments Being Tested
Sixty patients scheduled for elective laparoscopic cholecystectomy will be ...
Status
Completed
Location
Tanta University Hospitals
Start Date
2020-01-22
Trial ID
NCT05369468
Treatments Being Tested
This is a randomized controlled parallel Group phase I study to investigate...
Status
Completed
Location
University Hospital Bordeaux (Pellegrin Hospital)
Start Date
2014-12-11
Trial ID
NCT02270489
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of 2 dif...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02304185
Treatments Being Tested
Primary objective: To compare the event rate of CDI in groups assigned to A...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00772343
The primary objective of the phase I trial is to evaluate the safety and to...
Status
Recruiting
Location
Zigong Center for Disease Control and Prevention
Start Date
2026-05-14
Trial ID
NCT07582796
Treatments Being Tested
This is a first in man study evaluating the tolerability and immunogenicity...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00851266
Treatments Being Tested